Coupling of transcription with alternative splicing: RNA pol II promoters modulate SF2/ASF and 9G8 effects on an exonic splicing enhancer

Molecular Cell

Volumn 4, Issue 2, 1999, Pages 251-258

  Cramer, Paula ^a   Cáceres, Javier F ^b   Cazalla, Demián ^a   Kadener, Sebastián ^a   Muro, Andrés F ^c   Baralle, Francisco E ^c   Kornblihtt, Alberto R ^a  

^a INSTITUTO DE FISIOLOGÍA   (Argentina)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

^c INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLOBIN; DNA; FIBRONECTIN; MESSENGER RNA; POL PROTEIN; PROTEIN; RNA; TRANSCRIPTION FACTOR;

ARTICLE; BINDING SITE; CELL LINE; ENHANCER REGION; EXON; GENETIC LINKAGE; HUMAN; MOLECULAR INTERACTION; RNA SPLICING; TRANSCRIPTION REGULATION;

EID: 0033180615     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(00)80372-X     Document Type: Article

References (44)

1. Alonso, C.A., Pesce, C.G., and Kornblihtt, A.R. (1996). The CCAAT-binding proteins CP1 and NF-I cooperate with ATF-2 in the transcription of the fibronectin gene. J. Biol. Chem. 271, 22271-22279.
2. Cáceres, J.F., Stamm, S., Helfman, D.M., and Krainer, A.R. (1994). Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. Science 265, 1706-1709.
3. Cáceres, J.F., Misteli, T., Screaton, G.R., Spector, D.L., and Krainer, A.R. (1997). Role of the modular domains of SR proteins in subnuclear localization and alternative splicing specificity. J. Cell Biol. 138, 225-238.
4. Cáceres, J.F., Screaton, G.R., and Krainer, A.R. (1998). A specific subset of SR proteins shuttles continuously between the nucleus and the cytoplasm. Genes Dev. 12, 55-66.
5. Cao, W., Jamison, S.F., and Garcia-Blanco, M.A. (1997). Both phosphorylation and dephosphorylation of ASF/SF2 are required for pre-mRNA splicing in vitro. RNA 3, 1456-1467.
6. Caputi, M., Casari, G., Guenzi, S., Tagliabue, R., Sidoli, A., Melo, C.A., and Baralle, F.E. (1994). A novel bipartite splicing enhancer modulates the differential processing of the human fibronectin EDA exon. Nucleic Acids Res. 22, 1018-1022.
7. Cavaloc, Y., Bourgeois, C.F., Kister, L., and Stévenin, J. (1999) The splicing factors 9G8 and SRp20 transactivate splicing through different and specific enhancers. RNA 5, 468-483.
8. Chomczynski, P., and Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Annal. Biochem. 162, 156-159.
9. Corden, J.L., and Patturajan, M. (1997). A CTD function linking transcription to splicing. Trends Biochem. Sci. 22, 413-416.
10. Cramer, P., Pesce, C.G., Baralle, F.E., and Kornblihtt, A.R. (1997). Functional association between promoter structure and transcript alternative splicing. Proc. Natl. Acad. Sci. USA 94, 11456-11460.
11. Fu, X.-D. (1993). Specific commitment of different pre-mRNAs to splicing by single SR proteins. Nature 365, 82-85.
12. Ge, H., and Manley, J.L. (1990). A protein factor, ASF, controls cell-specific alternative splicing of SV40 early pre-mRNA in vitro. Cell 62, 25-34.
13. Ge, H., Zuo, P., and Manley, J.L. (1991). Primary structure of the human splicing factor ASF reveals similarities with Drosophila regulators. Cell 66, 373-382.
14. Ge, H., Si, Y., and Wolffe, A.P. (1998). A novel transcriptional coactivator, p52, funcionally interacts with the essential splicing factor ASF/SF2. Mol. Cell 2, 751-759.
15. Hertel, K.J., Lynch, K.W., and Maniatis, T. (1997). Common themes in the function of transcription and splicing enhancers. Curr. Opin. Cell Biol. 9, 3751-3757.
16. Hirose, Y., and Manley, J.L. (1998). RNA polymerase II is an essential mRNA polyadenylation factor. Nature 395, 93-96.
17. Jiménez-García, L.F., and Spector, D.L. (1993). In vivo evidence that transcription and splicing are coordinated by a recruiting mechanism. Cell 73, 47-59.
18. Kornblihtt, A.R., Vibe-Pedersen, K., and Baralle, F.E. (1984). Human fibronectin: Molecular cloning evidence for two mRNA species differing by an internal segment coding for a structural domain. EMBO J. 3, 221-226.
19. Kornblihtt, A.R., Pesce, C.G., Alonso, C.R., Cramer, P., Srebrow, A., Werbajh, S.E., and Muro, A.F. (1996). The fibronectin gene as a model for splicing and transcription studies. FASEB J. 10, 248-257.
20. Krainer, A.R., Conway, G.C., and Kozak, D. (1990). Purification and characterization of pre-mRNA splicing factor SF2 from Hela cells. Genes Dev. 4, 1158-1171.
21. Krainer, A.R., Mayeda, A., Kozak, D., and Binns, G. (1991). Functional expression of cloned human splicing factor SF2: Homology to RNA-binding proteins U1 70k, and Drosophila splicing regulators. Cell 66, 383-394.
22. Lavigueur, A., La Branche, H., Kornblihtt, A.R., and Chabot, B. (1993). A splicing enhancer in the human fibronectin alternate exon EDI interacts with SR proteins and stimulates U2 snRNP binding. Genes Dev. 7, 2405-2417.
23. Manley, J.L., and Tacke, R. (1996). SR proteins and splicing control. Genes Dev. 10, 1569-1579.
24. Mardon, H.J., Sebastio, G., and Baralle, F.E. (1987). A role for exon sequences in alternative splicing of the human fibronectin gene. Nucleic Acids Res. 15, 7725-7733.
25. McCracken, S., Fong, N., Yankulov, K., Ballantyne, S., Pan, G., Greenblatt, J., Patterson, S.D., Wickens, M., and Bentley, D.L. (1997). The C-terminal domain of RNA polymerase II couples mRNA processing to transcription. Nature 385, 357-361.
26. Misteli, T., and Spector, D.L. (1998). The cellular organization of gene expression. Curr. Opin. Cell Biol. 10, 323-331
27. Misteli, T., Cáceres, J.F., and Spector, D.L. (1997). The dynamics of a pre-mRNA splicing factor in living cells. Nature 387, 523-527
28. Muro, A.F., Caputi, M., Pariyarath, R., Pagani, F., Buratti, E., and Baralle, F.E. (1999). Regulation of fibronectin EDA exon alternative splicing: Possible role of RNA secondary structure for enhancer display. Mol. Cell. Biol. 19, 2657-2671.
29. Moore, M.J., Query, C.C., and Sharp, P.A. (1993). Splicing of precursors to messenger RNAs by the spliceosome. In The RNA World, R.F. Gesteland and J.F. Atkins, eds. (Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press), pp. 303-358.
30. Mortillaro, M.J., Blencowe, B.J., Wei, X., Nakayasu, H., Du, L., Warren, S.L., Sharp, P.A., and Berezney, R. (1996). A hyperphosphorylated form of the large subunit of RNA polymerase II is associated with splicing complexes and the nuclear matrix. Proc. Natl. Acad. Sci. USA 93, 8253-8257.
31. Nayler, O., Cap, C., and Stamm, S. (1998a) Human transformer-2-beta gene (SFRS10): Complete nucleotide sequence, chromosomal localization, and generation of a tissue-specific isoform. Genomics 53, 191-202.
32. Nayler, O., Strätling, W., Bourquin, J.-P., Stagljar I., Lindemann, L., Jasper, H., Hartmann, A.M., Fackelmazer, F.O., Ullrich, A., and Stamm, S. (1998b). SAF-B protein couples transcription and pre-mRNA splicing to SAR/MAR elements. Nucleic Acids Res. 26, 3542-3549.
33. O'Brien, T., Hardin, S., Greenleaf, A., and Lis, J.T. (1994). Phosphorylation of RNA polymerase II C-terminal domain and transcriptional elongation. Nature 370, 75-77.
34. Sun, Q., Mayeda, A., Hampson, R.K., Krainer, A.R., and Rottman, F.M. (1993). General splicing factor SF2/ASF promotes alternative splicing by binding to an exonic splicing enhancer. Genes Dev. 7, 2598-2608.
35. Tacke, R., and Manley, J.L. (1995). The human splicing factors ASF/SF2 and SC35 possess distinct, functionally significant RNA binding specificities. EMBO J. 14, 3540-3551.
36. Tacke, R., Tohyama, M., Ogawa, S., and Manley, J.L. (1998). Human Tra2 proteins are sequence-specific activators of pre-mRNA splicing. Cell 93, 139-148.
37. Vibe-Pedersen, K., Kornblihtt, A.R., and Baralle, F.E. (1984). Expression of a human α-globin/fibronectin gene hybrid generates two mRNAs by alternative splicing. EMBO J. 3, 2511-2516.
38. Wang, J., Takagaki, Y., and Manley, J.L. (1996). Targeted disruption of an essential vertebrate gene: ASF/SF2 is required for cell viability. Genes Dev. 10, 2588-2599.
39. Wang, J., Xiao, S.-H., and Manley, J.L. (1998). Genetic analysis of the SR protein ASF/SF2: Interchangeability of RS domains and negative control of splicing. Genes Dev. 12, 2222-2233.
40. Xiao, S.-H., and Manley, J.L. (1997). Phosphorylation of the ASF/SF2 RS domain affects both protein-protein and protein-RNA interactions and is necessary for splicing. Genes Dev. 11, 334-344.
41. Xing, Y., Johnson, C.V., Dobner, P.R., and Bentley Lawrence, J. (1993). Higher level organization of individual gene transcription and RNA splicing. Science 259, 1326-1329.
42. Yankulov, K., Blau, J., Purton, T., Roberts, S., and Bentley, D.L. (1994). Transcriptional elongation by RNA polymerase II is stimulated by transactivators. Cell 77, 749-759.
43. Yuryev, A., Patturajan, M., Litingtung, Y., Joshi, R.V., Gentile, C., Gebara, M., and Corden, J.L. (1996). The C-terminal domain of the largest subunit of RNA polymerase II interacts with a novel set of serine/arginine-rich proteins. Proc. Natl. Acad. Sci. USA 93, 6975-6980.
44. Zahler, A.M., Neugebauer, K.M., Lane, W.S., and Roth, M.B. (1992). SR proteins: A conserved family of pre-mRNA splicing factors. Genes Dev. 6, 837-847.